For more information, please select from the list below:

Program Information

Statement of Need
Advances in the applications, technologies and methodologies of radiation oncology continue to evolve rapidly, creating a need for continual learning. The 2008 Annual Meeting Scientific Program is designed to disseminate new scientific findings and technical innovations, and
expand basic knowledge relevant to clinical practice and to the improvement of patient outcomes.

Program Description and Objectives
The educational elements of this program are targeted at oncologists of all disciplines, physicists, biologists, nurses, dosimetrists, therapists and other professionals involved in radiation therapy. Attendees will receive state-of-the-art practice information relating
to radiation, surgical and medical oncology. Embracing the multidisciplinary approach to cancer care is essential to quality care. Research presented from medical and surgical oncologists, pathologists and allied professionals will enhance the interdisciplinary nature of the program. The program will include presentations on standard, investigational and experimental therapeutics, image guided radiation therapy, intensity modulated radiation therapy, radionuclide therapy, treatment planning, alternative fractionation, emerging technologies, and molecular and radiation biology. Specific clinical areas include breast, central nervous system, gastrointestinal, genitourinary, gynecological, head and neck,
lung, lymphoma, musculoskeletal, pediatric and thoracic cancers. In addition, the program will address quality of life, supportive care, outcomes and health policy issues. These topics are addressed by a combination of educational sessions, panel discussions, proffered papers and posters. Educational sessions provide attendees with an essential review of timely
topics, panel discussions emphasize current controversies; proffered papers and poster presentations represent new research findings. This combination provides complementary coverage of a broad range of topics relevant to radiation oncology and members of the multidisciplinary care team.

Who Should Attend
This continuing medical education activity is designed to meet the interest of radiation oncologists, radiation oncology residents, radiation biologists, radiation physicists, dosimetrists, oncologists working in related specialties, radiation therapists, radiation
oncology nurses, radiation oncology administrators and all other health professionals involved in the field of radiation oncology.

Disclosure of Vested Interest
Presenters will disclose any vested interest or their intention to discuss off-label use of pharmaceuticals or devices, if applicable, to the audience at the beginning of their presentation and in accordance with ACCME standards and Food and Drug Administration
requirements. ASTRO’s scientific program may include presentations on drugs or devices, or uses of drugs or devices, which may not have been approved by the FDA or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. Please refer to the official prescribing information for approved indications,contraindications and warnings.

Disclaimer
ASTRO is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASTRO of the uses, products or techniques presented. All information on this Web site is current as of May 8, 2008, and is subject to change. Please visit the Web site frequently for updates.